The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. With approvals in a number of […]

The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications, accelerating early discovery innovation into the clinic. Understand the very latest […]

A Focus on Non-traditional Approaches in the Fight against Antimicrobial Resistance Sponsored by Scynexis CO-CHAIRS FOR 2020: Cara Cassino, Chief Medical Officer, Contrafect and Michael Dawson, Director, Mike Dawson Antimicrobial Research […]